Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors
Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW191 in treatment of advanced cancers including ovarian, endometrial, and non-small cell lung cancers Global Phase 1 clinical trial will evaluate the safety and tolerability of ZW191 in treatment of advanced cancers ...
| Ticker |
Sentiment |
Impact |
|
DSSMY
|
Neutral
|
3 %
|
|
JAZZ
|
Neutral
|
3 %
|
|
BGNE
|
Neutral
|
9 %
|
